Objective: The objective of this longitudinal, observational study was to investigate change over time in ability to perform activities of daily living in myotonic dystrophy type 1 (DM1).

Methods: Adults with genetically confirmed DM1 were recruited as part of the PhenoDM1 study in the UK. Data on activities of daily living were recorded through the DM1-Activ at baseline and a follow-up visit after 12 (± 3) months. A subset of patients had advanced genetic testing to determine the size of the progenitor allele.

Results: Our sample comprised 150 patients with DM1 (mean age: 45 years; 52% female). Mean follow-up was 383 days. Mean DM1-Activ total score at baseline was 71.24 (95% confidence interval 67.77-74.71) and at the follow-up visit 69.04 (65.54-72.54). Approximately 43% of patients had a lower score at the follow-up visit (indicating a decreased ability to perform activities of daily living), 24% a higher score (indicating an increased ability), and 33% the same score at baseline and follow-up. The mean annual change in the DM1-Activ total score, estimated at - 2.06 (- 3.54 to - 0.59), was significantly related to patients' baseline score, but not sex, disease duration, timed test results, or cytosine-thymine-guanine repeat length.

Conclusions: Change over time in ability to perform activities of daily living as recorded through the DM1-Activ varies substantially between patients with DM1. Our data contribute to the understanding of the natural evolution of the disease, and should be helpful to inform the design of future trials based on the DM1-Activ.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578145PMC
http://dx.doi.org/10.1007/s00415-020-09970-6DOI Listing

Publication Analysis

Top Keywords

activities daily
20
daily living
20
ability perform
16
perform activities
16
change time
12
time ability
12
follow-up visit
12
living myotonic
8
myotonic dystrophy
8
dystrophy type
8

Similar Publications

Objectives: Intrathecal baclofen (ITB) therapy is well documented as an effective treatment option for severe spasticity. Before ITB implantation, trials are conducted to evaluate efficacy, safety, and candidate suitability. While many centers conduct ITB trials, appropriate physical assessment has not been fully established.

View Article and Find Full Text PDF

Ebola virus (EBOV) causes severe disease in humans, with mortality as high as 90%. The small-molecule antiviral drug remdesivir (RDV) has demonstrated a survival benefit in EBOV-exposed rhesus macaques. Here, we characterize the efficacy of multiple intravenous RDV dosing regimens on survival of rhesus macaques 42 days after intramuscular EBOV exposure.

View Article and Find Full Text PDF

This study investigated the relationship between stepping-defined daily activity levels, time spent in different postures, and the patterns and intensities of stepping behaviour. Using a thigh-mounted triaxial accelerometer, physical activity data from 3547 participants with seven days of valid data were analysed. We classified days based on step count and quantified posture and stepping behaviour, distinguishing between indoor, community, and recreation stepping.

View Article and Find Full Text PDF

Research into new solutions for wearable assistive devices for the visually impaired is an important area of assistive technology (AT). This plays a crucial role in improving the functionality and independence of the visually impaired, helping them to participate fully in their daily lives and in various community activities. This study presents a bibliometric analysis of the literature published over the last decade on wearable assistive devices for the visually impaired, retrieved from the Web of Science Core Collection (WoSCC) using CiteSpace, to provide an overview of the current state of research, trends, and hotspots in the field.

View Article and Find Full Text PDF

The countermovement jump (CMJ) is a widely used test to assess lower body neuromuscular performance. This study aims to analyze the validity and reliability of an iOS application using artificial intelligence to measure CMJ height, force, velocity, and power in unloaded and loaded conditions. Twelve physically active participants performed 12 CMJs with external loads ranging from 0% to 70% of their body mass while being simultaneously monitored with a pair of force platforms and the My Jump Lab application.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!